Monitor Closely (1)telotristat ethyl will lower the level or effect of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
This info from Lexicomp® points out what you have to know about this medication, which includes what it’s employed for, how to consider it, its Unintended effects, and when to contact your healthcare company.
Repeatedly watch important symptoms throughout sedation and recovery interval if coadministered. Very carefully titrate remimazolam dose if administered with opioid analgesics and/or sedative/hypnotics.
Monitor Closely (one)glycerol phenylbutyrate will lower the extent or influence of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
topiramate will minimize the extent or influence of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
Stay away from or Use Alternate Drug. Prevent coadministration of delicate CYP3A4 substrates with ivosidenib or swap with different therapies. If coadministration is unavoidable, keep track of sufferers for lack of therapeutic result of those prescription drugs.
Reserve concomitant Suvorexant prescribing of these medicine in individuals for whom other treatment solutions are inadequate. Limit dosages and durations into the bare minimum necessary. Observe closely for signs of respiratory melancholy and sedation.
hydrocortisone will decrease the level or result of triazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
mifepristone will improve the level or influence of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Monitor Carefully (one)somapacitan will minimize the extent or influence of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
Estazolam is often a federal controlled material (C-IV) mainly because it includes estazolam that can be abused or bring on dependence. Continue to keep estazolam in a secure place to forestall misuse and abuse.
somatrogon will reduce the extent or impact of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
5, 2, and ten mg/kg/working day, respectively. Proof of tumorigenicity was not noticed in both examine. Incidence of hyperplastic liver nodules improved in woman mice specified the mid and superior dose stages. The significance of this kind of nodules in mice just isn't acknowledged at the moment.
chloramphenicol will improve the stage or result of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.